That's what the drug companies got in the Medicare prescription drug program. One industry publication, RPM Report, figures that the drug companies revenue will increase by $2 billion as a result of moving 6,400,000 old folks from Medicaid - where drug companies have to charge their lowest price - to Medicare - where there is no discount granted by the companies.
What could we do with an extra $2 billion?
No comments:
Post a Comment